CHARITY REGISTRATION NUMBER: 1148463
BLOODRUN EVS Unaudited Financial Statements
31 March 2023
TREMAINE
Chartered accountants 19 Tremaine Close Hartlepool TS27 3LE
BLOODRUN EVS
Financial Statements
Year ended 31 March 2023
| Page | |
|---|---|
| Trustees' annual report | 1 |
| Independent examiner's report to the trustees | 4 |
| Statement of financial activities | 5 |
| Statement of financial position | 6 |
| Notes to the financial statements | 7 |
BLOODRUN EVS
Trustees' Annual Report
Year ended 31 March 2023
The trustees present their report and the unaudited financial statements of the charity for the year ended 31 March 2023.
Reference and administrative details
Registered charity name BLOODRUN EVS Charity registration number 1148463 Principal office Commerce House 1 Exchange Square Middlesbrough TS1 1DE The trustees M J Dixon (Appointed 27 November 2022) S A Khan (Appointed 27 November 2022) M A Dickinson (Appointed 27 November 2022) B Hodgson K Bayne G Dixon M M Finegan A Finegan R Hodgson (Resigned 19 May 2023) Independent examiner Julie Todd Tremaine Chartered Certified Accountant 19 Tremaine Close Hartlepool TS27 3LE
Structure, governance and management
The organisation is a registered charity, registered with the Charity Commission of England & Wales. The charity is governed by its constitution dated 7 August 2012.
Objectives and activities
The object of the charity is:
To relieve sickness and protect public health by the provision of transport for urgently needed blood, drugs, human tissues and other medical requirements between hospitals, blood transfusion banks and other healthcare facilities.
To support human life by providing a free of charge transportation service to our local NHS and to other organisations with objectives similar to ours.
1
Trustees' Annual Report (continued)
BLOODRUN EVS
Year ended 31 March 2023
Achievements and performance
Through 22/23 the charity has seen a decrease in the demand on our service. We have continued to deliver a 24-hour service since COVID-19 to provide transport links in hours for both North Tees and South Tees trusts. The reduction can be attributed to the removed need of COVID-19 test transport, which was high in 21/22.
Even with the demand decreasing on our services, our call volumes have still been high including more ad-hoc calls. We successfully recruited 25 more volunteers to help provide the services, of which 20 are still with us today.
Our fundraising events have seen a greater diversity in the types and locations. We have started to get greater visibility in our south area of operations, resulting in greater interest from charitable groups for talks and fundraising days.
Within this financial year we held our first public Christmas raffle. We received great support from local businesses and individuals for prizes and sale of tickets. Expectations were to sell 3,000 tickets, but we soon surpassed that and ended with 4,600 tickets which raised an incredible amount of £4,600 (minus printing/processing costs). We will endeavour to do the same next year with earlier planning to hopefully raise a larger sum.
Our fleet replacement strategy has started to gain momentum with the aim to replace a bike and a car each year until each vehicle is replaced with a new, reliable replacement. We have separate, restricted funds to enable us to track and forecast our vehicle purchases. We will be working with our connections to gain support for our service in the hope of favourable discounts on our replacements.
Our stability as a group has remained relatively good. Our shift coverage was 95.4%, up slightly from 94.3% the previous year. We responded to 4,245 calls, with an almost even split of scheduled rota calls to ad-hoc calls. This is a decrease in total calls of 26%. Our fleet mileage was 130,863. This has also decreased by 33% with the decreased workload.
Going into 23/24, we will continually review the work we are undertaking to ensure that each call is the best use of our funds and resources. We have very recently started a new rota to facilitate out of hours surgeries in Redcar and Cleveland by providing an out of hours run to collect blood samples, arriving at James Cook the same day. We hope this will further achieve our mission of preventing suffering and providing earlier diagnosis.
Our digital presence continues to improve and allow us to be efficient in our operations. Our app, online dispatch system, online charity management and digital vehicle checks all help us to remove the need for manual triage and record keeping. Our IT platforms have been resilient through the entire year of operation. Innovation on the platform has stalled slightly, due to required refactoring of our systems to stay up to date with current technologies and enable us to do bigger and better things going forward.
Our corporate image continues to improve, and our service is seen as a professional one. We are highly regarded under the NABB umbrella as a group who innovate, and our success is regularly mentioned. Going forward with our fleet replacement strategy, we aim to have our vehicles project that image with the correct livery and equipment.
We wouldn’t be able to provide our life saving service without the group of dedicated volunteers we have. So, I’d like to thank them for their efforts over the past 12 months and hope our success is a driver for continued commitment to the life saving service we provide to the Cleveland and North Yorkshire areas.
2
BLOODRUN EVS
Trustees' Annual Report (continued)
Year ended 31 March 2023
Achievements and performance (continued)
Public Benefit
As we are all aware, our continued operations have significant benefit to the communities that we serve. Combining this with saving money for the NHS we should all be very proud of our ongoing achievements and the difference that we are making to the lives of those around us, every day.
When making operational decisions about the future activity of our charity, we always consider the benefit to the public. We will publish a "Summary of main activities undertaken" along with the Annual Accounts and Returns to the Charity Commission.
We will continue to consult with appropriate professionals, so we can continue to improve upon our Charities Commission compliance and governance matters during the coming year.
Financial review
The unrestricted reserves of the charity amounted to £107,761 of which free reserves (i.e. those not tied up in fixed assets) amounted to £50,860.
The trustees' annual report was approved on .............................. and signed on behalf of the board of trustees by:
M J Dixon Trustee
3
BLOODRUN EVS
Independent Examiner's Report to the Trustees of BLOODRUN EVS
Year ended 31 March 2023
I report to the trustees on my examination of the financial statements of BLOODRUN EVS ('the charity') for the year ended 31 March 2023.
Responsibilities and basis of report
As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the charity's financial statements carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the Act; or
-
the financial statements do not accord with those records; or
-
the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Julie Todd Tremaine Chartered Certified Accountant Independent Examiner
19 Tremaine Close Hartlepool TS27 3LE
4
BLOODRUN EVS
Statement of Financial Activities
Year ended 31 March 2023
| 2023 | 2022 | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | ||||
| funds | funds | Total funds | Total funds | ||
| Note | £ | £ | £ | £ | |
| Income and endowments | |||||
| Donations and legacies | 4 | 46,123 | 21,357 | 67,480 | 32,125 |
| Charitable activities | 5 | – | – | – | 138 |
| Other income | 6 | – | – | – | 9,627 |
|
|
|
|
||
| Total income | 46,123 | 21,357 | 67,480 | 41,890 | |
|
|
|
|
||
| Expenditure | |||||
| Expenditure on charitable activities | 7 | 49,902 | – | 49,902 | 54,388 |
|
|
|
|
||
| Total expenditure | 49,902 | – | 49,902 | 54,388 | |
|
|
|
|
||
|
|
|
|
||
| Net income/(expenditure) and net | |||||
| movement in funds | (3,779) | 21,357 | 17,578 | (12,498) | |
|
|
|
|
||
| Reconciliation of funds | |||||
| Total funds brought forward | 111,540 | 2,551 | 114,091 | 126,589 | |
|
|
|
|
||
| Total funds carried forward | 107,761 | 23,908 | 131,669 | 114,091 | |
|
|
|
|
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
The notes on pages 7 to 13 form part of these financial statements.
5
BLOODRUN EVS
Statement of Financial Position
31 March 2023
| 2023 | 2022 | ||
|---|---|---|---|
| Note | £ | £ | |
| Fixed assets | |||
| Tangible fixed assets | 11 | 56,901 | 71,995 |
| Current assets | |||
| Debtors | 12 | 488 | 506 |
| Cash at bank and in hand | 74,280 | 41,590 | |
|
|
||
| 74,768 | 42,096 | ||
|
|
||
| Net current assets | 74,768 | 42,096 | |
|
|
||
| Total assets less current liabilities | 131,669 | 114,091 | |
|
|
||
| Funds of the charity | |||
| Restricted funds | 23,908 | 2,551 | |
| Unrestricted funds | 107,761 | 111,540 | |
|
|
||
| Total charity funds | 13 | 131,669 |
114,091 |
These financial statements were approved by the board of trustees and authorised for issue on ........................, and are signed on behalf of the board by:
M J Dixon Trustee
The notes on pages 7 to 13 form part of these financial statements.
6
BLOODRUN EVS
Notes to the Financial Statements
Year ended 31 March 2023
1. General information
The charity is a public benefit entity and a registered charity in England and Wales and is unincorporated. The address of the principal office is Commerce House, 1 Exchange Square, Middlesbrough, TS1 1DE.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Charities Act 2011.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
There are no material uncertainties about the charity's ability to continue.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Fund accounting
Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes.
Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment.
Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income funds or endowment funds.
7
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2023
3. Accounting policies (continued)
Incoming resources
All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:
-
income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably.
-
legacy income is recognised when receipt is probable and entitlement is established.
-
income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers.
-
income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.
Resources expended
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
-
expenditure on raising funds includes the costs of all fundraising activities, events, noncharitable trading activities, and the sale of donated goods.
-
expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.
-
other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
8
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2023
3. Accounting policies (continued)
Tangible assets (continued)
An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other recognised gains and losses, unless it reverses a charge for impairment that has previously been recognised as expenditure within the statement of financial activities. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other recognised gains and losses, except to which it offsets any previous revaluation gain, in which case the loss is shown within other recognised gains and losses on the statement of financial activities.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Motor vehicles - 5% straight line Equipment - 25% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cashgenerating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.
For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the charity are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the charity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs.
Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted.
Debt instruments are subsequently measured at amortised cost.
9
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2023
3. Accounting policies (continued)
Financial instruments (continued)
Where investments in shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in income and expenditure. All other such investments are subsequently measured at cost less impairment.
Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Other financial instruments are subsequently measured at fair value, with any changes recognised in the statement of financial activities, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised under the appropriate heading in the statement of financial activities in which the initial gain was recognised.
For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Donations and legacies
| Unrestricted | Restricted | Total Funds | |
|---|---|---|---|
| Funds | Funds | 2023 | |
| £ | £ | £ | |
| Donations | |||
| Donations | 46,123 | 21,357 | 67,480 |
|
|
|
|
| 46,123 | 21,357 | 67,480 | |
|
|
|
|
| Unrestricted | Restricted | Total Funds | |
| Funds | Funds | 2022 | |
| £ | £ | £ | |
| Donations | |||
| Donations | 24,482 | – | 24,482 |
| Just Giving | 6,643 | – | 6,643 |
| Grants | |||
| Tees Bay Pilots | – | 250 | 250 |
| PD Ports | – | 750 | 750 |
|
|
|
|
| 31,125 | 1,000 | 32,125 | |
|
|
|
10
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2023
5. Charitable activities
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
|---|---|---|---|---|---|
| Funds | 2023 | Funds | 2022 | ||
| £ | £ | £ | £ | ||
| Refunds | – | – | 138 | 138 | |
|
|
|
|
||
| 6. | Other income | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2023 | Funds | 2022 | ||
| £ | £ | £ | £ | ||
| Other income type 1 | – | – | 9,627 | 9,627 | |
|
|
|
|
||
| 7. | Expenditure on charitable activities by fund type | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2023 | Funds | 2022 | ||
| £ | £ | £ | £ | ||
| General fund | 49,902 | 49,902 | 54,388 | 54,388 | |
|
|
|
|
||
| 8. | Net income/(expenditure) | ||||
| Net income/(expenditure) is stated after charging/(crediting): | |||||
| 2023 | 2022 | ||||
| £ | £ | ||||
| Depreciation of tangible fixed assets | 15,369 |
– |
9. Staff costs
The average head count of employees during the year was Nil (2022: Nil).
No employee received employee benefits of more than £60,000 during the year (2022: Nil).
10. Trustee remuneration and expenses
No remuneration or other benefits from employment with the charity or a related entity were received by the trustees.
11
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2023
11. Tangible fixed assets
| Motor | ||||
|---|---|---|---|---|
| vehicles | Equipment | Total | ||
| £ | £ | £ | ||
| Cost | ||||
| At 1 April 2022 | 106,901 | 911 | 107,812 | |
| Additions | – | 275 | 275 | |
|
|
|
||
| At 31 March 2023 | 106,901 | 1,186 | 108,087 | |
|
|
|
||
| Depreciation | ||||
| At 1 April 2022 | 35,738 | 79 | 35,817 | |
| Charge for the year | 15,092 | 277 | 15,369 | |
|
|
|
||
| At 31 March 2023 | 50,830 | 356 | 51,186 | |
|
|
|
||
| Carrying amount | ||||
| At 31 March 2023 | 56,071 | 830 | 56,901 | |
|
|
|
||
| At 31 March 2022 | 71,163 | 832 | 71,995 | |
|
|
|
||
| 12. | Debtors | |||
| 2023 | 2022 | |||
| £ | £ | |||
| Prepayments and accrued income | 488 |
506 |
13. Analysis of charitable funds Unrestricted funds
| Unrestricted funds | |||||
|---|---|---|---|---|---|
| At | At 31 March | ||||
| 1 | April 2022 | Income | Expenditure | 2023 | |
| £ | £ | £ | £ | ||
| General funds | 111,540 | 46,123 | (49,902) | 107,761 | |
|
|
|
|
||
| At | At 31 March | ||||
| 1 | April 2021 | Income | Expenditure | 2022 | |
| £ | £ | £ | £ | ||
| General funds | 125,038 |
40,890 |
(54,388) |
111,540 |
12
BLOODRUN EVS
Notes to the Financial Statements (continued)
Year ended 31 March 2023
13. Analysis of charitable funds (continued)
Restricted funds
| Restricted funds | ||||
|---|---|---|---|---|
| At | At 31 March | |||
| 1 April 2022 | Income | Expenditure | 2023 | |
| £ | £ | £ | £ | |
| New Bike Fund | 2,551 | 21,357 | – | 23,908 |
|
|
|
|
|
| At | At 31 March | |||
| 1 April 2021 | Income | Expenditure | 2022 | |
| £ | £ | £ | £ | |
| New Bike Fund | 1,551 | 1,000 | – | 2,551 |
|
|
|
|
|
| Analysis of net assets between funds | ||||
| Unrestricted | Restricted | Total Funds | ||
| Funds | Funds | 2023 | ||
| £ | £ | £ | ||
| Tangible fixed assets | 56,901 | – | 56,901 | |
| Current assets | 50,860 | 23,908 | 74,768 | |
|
|
|
||
| Net assets | 107,761 | 23,908 | 131,669 | |
|
|
|
||
| Unrestricted | Restricted | Total Funds | ||
| Funds | Funds | 2022 | ||
| £ | £ | £ | ||
| Tangible fixed assets | 71,995 | – | 71,995 | |
| Current assets | 39,545 | 2,551 | 42,096 | |
|
|
|
||
| Net assets | 111,540 | 2,551 | 114,091 | |
|
|
|
14. Analysis of net assets between funds
13